The appointments are designed to strengthen the organisation's ability to accelerate the adoption and spread of innovation across health and care.

Jane Ollis, chair of Health Innovation KSS, said: ‘We are delighted to welcome Nicolas and Gautam to our board. They join us at a pivotal moment for Health Innovation Kent Surrey Sussex as we prepare to launch our strategy to 2030. Their insight and challenge will help us strengthen our partnerships across the health and life sciences sectors, build on our growing leadership in data, digital and AI, and maximise the impact we deliver for patients, communities and the wider health and care system.'

Dr Huber is director of commercial operations and partnerships at the London Institute for Healthcare Engineering at King's College London, where he leads one of the UK's leading medical device translation programmes. He brings extensive experience in healthcare innovation, commercialisation and technology adoption, having previously served as director of innovation at King's College London, chief executive of a University of Cambridge spin-out and mentor to health technology start-ups.

Kainth is managing partner at TCP Health Ventures, a leading medtech-focused healthcare fund, and brings more than two decades of experience supporting healthcare innovation, investment and growth. Having overseen the deployment of more than US$1bn in capital globally, he offers deep expertise in helping innovative health technologies move from development to scale. His experience across the life sciences, medical technology and investment sectors will support Health Innovation KSS as it strengthens partnerships with innovators and expands its work in data, digital and AI enabled innovation.